SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parmax Pharma informs about appointment of CS cum CO

25 Mar 2026 Evaluate
Parmax Pharma has informed that on the basis of recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has at their meeting held today Wednesday, March 25, 2026 have considered and approved the appointment of Bhakti Aghera (ICSI Membership No. A68683) as Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company with effect from March 24, 2026. Details with respect to Change in Key Managerial Personnel as required under Regulation 30 read with Para A of Part A of Schedule III of the Listing Regulations and SEBI circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, as amended are mentioned in ‘Annexure - A’.

The above information is a part of company’s filings submitted to BSE.

Parmax Pharma Share Price

30.65 -0.15 (-0.49%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×